COVID-19 vaccines (FOI)
COVID-19 vaccines (FOI)Produced by the Freedom of Information office
Authored by Government of Jersey and published on 22 February 2022.
Prepared internally, no external costs.
Please confirm the following questions.
What exact date did Jersey order its first batches of the "covid vaccines"?
Does the government acknowledge that the "covid vaccines" are in their human trial?
How much has been spent on importation of "vaccines" to date?
Who supplied the "vaccines" and which country did they come from?
How much money has the government spent on the "covid vaccines" to date?
What steps where taken locally to ensure the "covid vaccine" substances were fit for human consumption / fit for purpose?
The information sought pertaining to the above transparent questions should aim to demonstrate clear rationale that the current human trial "vaccines" where safely procured and that expert duty of care was exercised BEFORE the next step of offering them to the public as a cure for a so called new virus (that has never been isolated or purified from a human but only seems to appear IN SILICO - on government modelling.
The Government of Jersey received its first COVID-19 vaccine stocks on 09 December 2020.
The Government of Jersey Scientific and Technical Advisory Committee (STAC) considers and complies with the advice of the UK Joint Committee on Vaccination and Immunisation (JCVI). JCVI guidance issued for each cohort specific vaccination workstreams is informed by worldwide peer reviewed evidence. In addition, peer reviewed evidence relating to vaccination is summarised in the 'Green Book':
COVID-19: the green book, chapter 14a (www.gov.uk)
None, as the UK Government has contracted with vaccine suppliers and the Government of Jersey (Crown Dependency) receive vaccines as part of this arrangement.
All COVID-19 vaccines have been obtained from the UK as part of their overall vaccine programme. The UK hold information on their country of origin.
None – please see response to question C.
All COVID-19 vaccines used as part of the UK and Jersey vaccination programme were approved by the UK medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), as being safe and effective for use in humans. Approved vaccines were then used in accordance with guidance issued by the UK Joint Committee on Vaccination and Immunisation (JCVI).
Medicines and Healthcare products Regulatory Agency (www.gov.uk)